MT-1s potent MC1R activation drives melanin synthesis independent of UV radiation , providing experimental control over the melanogenesis pathway without the confounding DNA damage, oxidative stress, and inflammatory responses that UV exposure produces alongside its melanogenic effects
A slightly altered form of Wegovy for oral use was approved in December 2025, but it has similar side effects to the injectable form[
FormBlends own clinical focus is on compounded semaglutide and tirzepatide GLP-1 programs for weight management, a separate category from scar treatment
The honest catch, because there's always one: roughly 6% discontinued at the highest doses for adverse events GI being the most common (nausea, vomiting, constipation), usually mild-to-moderate
However, this isn't necessarily a good thing
At 330 mcg per dose: 10,000 mcg 330 mcg 30 doses per vial